Rhythm Pharmaceuticals, Inc. announced that it will receive $40,949,999 in a round of funding on January 6, 2017. The company will issue series A preferred stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The company intends this offering to last more than one year.